Page last updated: 2024-10-29

ketamine and Restless Leg Syndrome

ketamine has been researched along with Restless Leg Syndrome in 2 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Research Excerpts

ExcerptRelevanceReference
"Oral Ketamine, an NMDA receptor antagonist, can be used to treat restless legs syndrome."7.71Oral ketamine: a promising treatment for restless legs syndrome. ( Friedman, R; Kapur, N, 2002)
"Oral Ketamine, an NMDA receptor antagonist, can be used to treat restless legs syndrome."3.71Oral ketamine: a promising treatment for restless legs syndrome. ( Friedman, R; Kapur, N, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Friedman, R2
Kapur, N1

Other Studies

2 other studies available for ketamine and Restless Leg Syndrome

ArticleYear
Ketamine for restless legs syndrome.
    Anesthesia and analgesia, 2003, Volume: 96, Issue:4

    Topics: Excitatory Amino Acid Antagonists; Humans; Ketamine; Magnesium; Receptors, N-Methyl-D-Aspartate; Res

2003
Oral ketamine: a promising treatment for restless legs syndrome.
    Anesthesia and analgesia, 2002, Volume: 94, Issue:6

    Topics: Administration, Oral; Aged; Back Pain; Excitatory Amino Acid Antagonists; Female; Humans; Intermitte

2002